The Department of Medicine is proud to announce that 154 of our faculty have been selected for the 2024 Castle Connolly Top Doctors® list. The Top Doctors® selection process is entirely merit-based. Doctors cannot pay to be listed. These doctors are best-in-class healthcare providers, embodying excellence in clinical care as well as interpersonal skills. More […]
In a world where healthcare often operates on rigid schedules and within traditional settings, there exists a growing need to adapt to the realities of those who cannot easily access or adhere to such structures. This is where organizations like Street Med STL step in, redefining healthcare delivery by taking it to the streets, quite […]
Collaboration with BJC HealthCare, Schnucks supports healthy eating to combat chronic disease
More than 184 million people, exceeding 61% of the U.S. population, are likely to have some type of cardiovascular disease (CVD) and total CVD-related costs are expected to triple to $1.8 trillion by 2050, according to projections reported in two new American Heart Association presidential advisories
May 17, 2024: “Measure Your Blood Pressure Accurately, Control It, Live Longer” The important World Hypertension Day was first held on 14 May 2005, and has since become an ever-expanding yearly event. This brief provides an update on high-impact hypertension-related research in Nigeria supported by Washington University. Hypertension, also known as raised blood pressure, affects […]
Expanded services aimed at reducing region’s high STI rates, disparities in sexual health The St. Louis area has some of the highest rates of sexually transmitted infections (STIs) in the country, with the burden falling particularly heavily on Black residents and people with sexual orientations and gender identities that are marginalized.
Rare diseases are just what their name implies – each one affects a limited number of people. But with this rarity comes unique challenges, and among the biggest challenges faced by these patients are the roadblocks they encounter with gathering information about their conditions, being properly diagnosed, and finding the best resources and treatment options […]
The multidisciplinary Structural Intervention group, including Cardiovascular Division faculty members Drs. Zajarias, Sintek, Lasala, and Quader, along with colleagues in Cardiothoracic Surgery, recently performed the first JenaValve procedure for aortic regurgitation at the Barnes-Jewish Hospital site.
DOLF researchers announce initiation of a major a new clinical trial of treatments for onchocerciasis in Liberia. The study will compare the safety and efficacy of three new combination treatments with a reference treatment of albendazole plus ivermectin.
ST. LOUIS – Barnes-Jewish Hospital is introducing the 12th sickle cell treatment center in the country. The center is revolutionizing healthcare for the underrepresented community affected by the disease.
New network to evaluate emerging technologies in diverse populations Washington University School of Medicine in St. Louis is joining a new clinical trials network launched by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to investigate emerging technologies for cancer screening, with the goal of reducing cancer-related illnesses and deaths. […]
Siteman Cancer Center, based at Barnes-Jewish Hospital and the School of Medicine, is one of the first centers nationwide to offer a newly approved cell-based immunotherapy that targets melanoma.
A new clinic headed by Ying (Maggie) Chen, MD, PhD, Associate Professor of Medicine, Nephrology, focuses on helping patients with a genetic form of renal fibrosis – autosomal dominant tubulointerstitial kidney disease (ADTKD) – which ultimately leads to chronic kidney disease (CKD).